BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones GM, Nock MK. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. J Psychopharmacol 2022;:2698811211066714. [PMID: 34983261 DOI: 10.1177/02698811211066714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Jones GM. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. J Psychopharmacol 2022. [DOI: 10.1177/02698811221127304] [Reference Citation Analysis]
2 Yang KH, Han BH, Palamar JJ. Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults. Addict Behav 2022;132:107343. [PMID: 35525189 DOI: 10.1016/j.addbeh.2022.107343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology 2022;218:109220. [PMID: 35987353 DOI: 10.1016/j.neuropharm.2022.109220] [Reference Citation Analysis]
4 Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Front Psychiatry 2022;13:917199. [DOI: 10.3389/fpsyt.2022.917199] [Reference Citation Analysis]
5 Bosch OG, Halm S, Seifritz E. Psychedelics in the treatment of unipolar and bipolar depression. Int J Bipolar Disord 2022;10:18. [PMID: 35788817 DOI: 10.1186/s40345-022-00265-5] [Reference Citation Analysis]
6 Jones G, Ricard JA, Lipson J, Nock MK. Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Sci Rep 2022;12:4099. [PMID: 35393455 DOI: 10.1038/s41598-022-08085-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jones GM, Nock MK. Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study. Sci Rep 2022;12:2574. [PMID: 35173246 DOI: 10.1038/s41598-022-06580-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Young AH. The age of psychedelics. J Psychopharmacol 2022;36:3-5. [DOI: 10.1177/02698811211070065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]